• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket

    3/27/24 8:14:28 AM ET
    $ABTS
    $AKLI
    $DRCT
    $FRGE
    Computer Software: Programming Data Processing
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ABTS alert in real time by email

    Shares of MariaDB plc (NYSE:MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ:PRGS) announced that it is possibly considering an offer for the company.

    MariaDB shares jumped 100.4% to $0.4530 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Destiny Tech100 Inc (NASDAQ:DXYZ) rose 52.9% to $13.76 in pre-market trading after gaining 9% on Tuesday.
    • PaySign, Inc. (NASDAQ:PAYS) gained 25.2% to $4.23 in pre-market trading after the company announced better-than-expected fourth-quarter results.
    • Hitek Global Inc. (NASDAQ:HKIT) gained 19.1% to $1.69 in pre-market trading.
    • The ONE Group Hospitality, Inc. (NASDAQ:STKS) shares rose 13.2% to $4.54 in pre-market trading after the company announced that it will acquire Safflower Holdings.
    • nCino, Inc. (NASDAQ:NCNO) gained 11.7% to $33.72 in pre-market trading as the company reported better-than-expected fourth-quarter results and issued FY25 adjusted earnings guidance above estimates..
    • Nuvation Bio Inc. (NASDAQ:NUVB) shares rose 11.5% to $3.21 in pre-market trading. Nuvation Bio shares gained 28% on Tuesday after BTIG upgraded the stock from Neutral to Buy.
    • Trump Media & Technology Group Corp. (NASDAQ:DJT) gained 11.5% to $64.70 in pre-market trading after jumping 16% on Tuesday.
    • MediciNova, Inc. (NASDAQ:MNOV) climbed 10.2% to $1.50 in pre-market trading. MediciNova received a Notice of Allowance from Japan Patent Office for MN-166 in macular injury treatment.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) gained 6.3% to $20.50 in pre-market trading. Robinhood launched its Gold Card, offering a 1% boost on Gold deposits and a redesigned app. The announcement was made at its first-ever keynote event.

    Losers

    • Direct Digital Holdings, Inc. (NASDAQ:DRCT) dipped 39.8% to $15.95 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
    • Velo3D, Inc. (NYSE:VLD) declined 34.1% to $0.3820 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
    • JOANN Inc. (NASDAQ:JOAN) fell 30.9% to $0.0760 pre-market trading after dipping over 6% on Tuesday. The Nasdaq recently determined that the company is no longer suitable for listing and its stock will be suspended on March 28.
    • LuxUrban Hotels Inc. (NASDAQ:LUXH) fell 20.5% to $1.70 pre-market trading after the company issued preliminary unaudited 2023 fourth quarter and full year financial results.
    • GameStop Corp. (NYSE:GME) shares fell 14.9% to $13.19 in pre-market trading as the company posted weaker-than-expected results for its fourth quarter on Tuesday.
    • Akili, Inc. (NASDAQ:AKLI) shares tumbled 13.6% to $0.3289 in pre-market trading. The company received a notice of allowance for U.S. Patent Application 17/890,478 titled Cognitive Platform For Deriving Effort Metric For Optimizing Cognitive Treatment (Using Data Computed With Artificial Neural Network Or Deep Learning Techniques)
    • Forge Global Holdings, Inc. (NYSE:FRGE) fell 12.4% to $2.32 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
    • Mesoblast Limited (NASDAQ:MESO) shares dropped 12.1% to $3.45 in pre-market trading. Mesoblast shares jumped over 78% on Tuesday after the FDA informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L for treatment of pediatric patients with steroid-refractory acute graft versus host disease.
    • MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) fell 10.4% to $1.03 in pre-market trading.
    • Abits Group Inc. (NASDAQ:ABTS) fell 7.7% to $0.72 in pre-market trading after gaining 7% on Tuesday.

     

    Now Read This: Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money'

    Get the next $ABTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABTS
    $AKLI
    $DRCT
    $FRGE

    CompanyDatePrice TargetRatingAnalyst
    Robinhood Markets Inc.
    $HOOD
    4/21/2026$120.00 → $110.00Overweight
    KeyBanc Capital Markets
    Robinhood Markets Inc.
    $HOOD
    4/20/2026$105.00 → $115.00Outperform
    Mizuho
    Robinhood Markets Inc.
    $HOOD
    4/8/2026$75.00Mkt Perform
    Keefe Bruyette
    nCino Inc.
    $NCNO
    4/1/2026$22.00Neutral → Overweight
    Piper Sandler
    Robinhood Markets Inc.
    $HOOD
    3/26/2026$88.00Buy
    Jefferies
    Medicinova Inc
    $MNOV
    3/16/2026$10.00Buy
    H.C. Wainwright
    Robinhood Markets Inc.
    $HOOD
    2/11/2026$135.00 → $100.00Buy
    Needham
    Robinhood Markets Inc.
    $HOOD
    2/9/2026$125.00Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $ABTS
    $AKLI
    $DRCT
    $FRGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wentworth Kerry

    4 - Nuvation Bio Inc. (0001811063) (Issuer)

    4/21/26 4:35:16 PM ET
    $NUVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Liu Dongfang

    4 - Nuvation Bio Inc. (0001811063) (Issuer)

    4/21/26 4:34:07 PM ET
    $NUVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Bhatt Baiju

    4 - Robinhood Markets, Inc. (0001783879) (Issuer)

    4/20/26 6:07:42 PM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    $ABTS
    $AKLI
    $DRCT
    $FRGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets reiterated coverage on Robinhood Markets with a new price target

    KeyBanc Capital Markets reiterated coverage of Robinhood Markets with a rating of Overweight and set a new price target of $110.00 from $120.00 previously

    4/21/26 9:33:04 AM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    Mizuho reiterated coverage on Robinhood Markets with a new price target

    Mizuho reiterated coverage of Robinhood Markets with a rating of Outperform and set a new price target of $115.00 from $105.00 previously

    4/20/26 9:28:24 AM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    Keefe Bruyette resumed coverage on Robinhood Markets with a new price target

    Keefe Bruyette resumed coverage of Robinhood Markets with a rating of Mkt Perform and set a new price target of $75.00

    4/8/26 8:38:05 AM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    $ABTS
    $AKLI
    $DRCT
    $FRGE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ABTS
    $AKLI
    $DRCT
    $FRGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Direct Digital Holdings Announces Reverse Stock Split

    HOUSTON, April 23, 2026 /PRNewswire/ -- Direct Digital Holdings, Inc. (NASDAQ:DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP") and Orange 142, LLC ("Orange 142"), today announced a 4-to-1 reverse stock split of all classes of its common stock. The Company expects the Class A common stock to begin trading on a split-adjusted basis on The Nasdaq Stock Market as of the commencement of trading on April 27, 2026. The reverse stock split is intended to allow the Company to maintain compliance with Nasdaq's minimum bid price requirement of $1.00 per share.As previously ann

    4/23/26 8:30:00 AM ET
    $DRCT
    Advertising
    Consumer Discretionary

    nCino Announces Nick Edwards as Managing Director for APAC

    WILMINGTON, N.C. and SYDNEY, April 22, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ:NCNO), the platform for agentic banking, today announced Nick Edwards as the new Managing Director for the APAC region. Edwards is a seasoned commercial and regional leader with deep expertise across financial services. With nearly two decades of experience across the region, he has developed an intimate understanding of the unique dynamics, customer needs and market opportunities that define financial services in the Asia-Pacific region. Most recently, Edwards served as Chief Commercial Officer, APAC at FNZ Group. Prior to that, he spent more than six years at Temenos and other financial services provider

    4/22/26 5:30:00 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Robinhood Ventures Fund I (RVI) Announces $75M Investment in OpenAI

    RVI) announced it has closed an investment in OpenAI. On April 17, 2026 RVI purchased approximately $75 million of common stock of OpenAI. " data-filename="image1.png"> MENLO PARK, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Today, Robinhood Ventures Fund I (NYSE:RVI) announced it has closed an investment in OpenAI. On April 17, 2026 RVI purchased approximately $75 million of common stock of OpenAI. "OpenAI is one of the frontier artificial intelligence companies, and we are incredibly proud to add them to the Fund," said Sarah Pinto, President of Robinhood Ventures Fund I. "As one of RVI's largest investments to date, this underscores our core mission to provide everyday investors wi

    4/22/26 8:00:00 AM ET
    $HOOD
    $RVI
    Investment Bankers/Brokers/Service
    Finance

    $ABTS
    $AKLI
    $DRCT
    $FRGE
    SEC Filings

    View All

    Direct Digital Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Direct Digital Holdings, Inc. (0001880613) (Filer)

    4/23/26 8:38:58 AM ET
    $DRCT
    Advertising
    Consumer Discretionary

    SEC Form DEFA14A filed by Robinhood Markets Inc.

    DEFA14A - Robinhood Markets, Inc. (0001783879) (Filer)

    4/22/26 4:26:56 PM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    SEC Form DEF 14A filed by Robinhood Markets Inc.

    DEF 14A - Robinhood Markets, Inc. (0001783879) (Filer)

    4/22/26 4:04:21 PM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    $ABTS
    $AKLI
    $DRCT
    $FRGE
    Leadership Updates

    Live Leadership Updates

    View All

    nCino Appoints Keith Kettell as Chief Revenue Officer to Lead Next Phase of Growth

    WILMINGTON, N.C., March 31, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ:NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced the appointment of Keith Kettell as Chief Revenue Officer, effective April 1. Kettell brings more than two decades of experience building and scaling go-to-market organizations in the technology and financial services sectors. Earlier in his career, he spent seven years at Salesforce, where he was instrumental in building the company's financial services go-to-market from the ground up, growing it into Salesforce's largest and fastest-growing industry vertical. He went on to join PagerDuty's Senior Leadership Team, responsibl

    3/31/26 4:05:00 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast

    NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the appointment of Teresa Montagut MD, PhD in the newly established position of Head of Clinical Development and Medical Affairs reporting to the Chief Medical Officer Dr. Eric Rose. In this role, Teresa will lead Mesoblast's medical affairs organization, fostering clinical collaborations and spearheading investigator-initiated trials, enhancing clinical and medical communications, and engaging with healthcare professionals. She will play a critical role in unlocking the value of Mesoblast's cell therapy programs i

    3/11/26 7:21:39 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    $ABTS
    $AKLI
    $DRCT
    $FRGE
    Financials

    Live finance-specific insights

    View All

    Direct Digital Holdings Announces Reverse Stock Split

    HOUSTON, April 23, 2026 /PRNewswire/ -- Direct Digital Holdings, Inc. (NASDAQ:DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP") and Orange 142, LLC ("Orange 142"), today announced a 4-to-1 reverse stock split of all classes of its common stock. The Company expects the Class A common stock to begin trading on a split-adjusted basis on The Nasdaq Stock Market as of the commencement of trading on April 27, 2026. The reverse stock split is intended to allow the Company to maintain compliance with Nasdaq's minimum bid price requirement of $1.00 per share.As previously ann

    4/23/26 8:30:00 AM ET
    $DRCT
    Advertising
    Consumer Discretionary

    Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026

    NEW YORK, April 20, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it will host a conference call and webcast on Monday, May 4, 2026, at 4:30 p.m. ET to discuss its financial results and business updates for the first quarter of 2026. Investors and the general public are invited to listen to the live webcast and may register on the Investor Relations section of the Nuvation Bio website. To access the live conference call, participants can dial +1 833-461-5787 (

    4/20/26 4:05:00 PM ET
    $NUVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

    NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform for precision-enhanced augmentation of therapeutic mesenchymal lineage stromal cell (MSC) products. Mesoblast plans to incorporate the engineered CARs to further boost effectiveness of Mesoblast's products, with the goal of enhancing the target specificity and augmenting inherent properties of immunomodulation and tissue regeneration. Mesoblast's MSC technology platforms, including the first and on

    4/14/26 8:10:56 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABTS
    $AKLI
    $DRCT
    $FRGE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by nCino Inc.

    SC 13D/A - nCino, Inc. (0001902733) (Subject)

    12/12/24 6:29:06 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Direct Digital Holdings Inc.

    SC 13D/A - Direct Digital Holdings, Inc. (0001880613) (Subject)

    11/22/24 4:11:23 PM ET
    $DRCT
    Advertising
    Consumer Discretionary